New Haven, CT 的 轉移性癌症 臨床試驗
23 項針對 轉移性癌症 的研究正在 New Haven（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)
招募中1/2 期
- Avenzo Therapeutics Recruiting Site, New Haven
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
招募中1/2 期
- Yale Cancer Center, New Haven
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
招募中1 期
- Yale - New Haven Hospital, New Haven
A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid Tumours
招募中1/2 期
- Yale Cancer Center-Yale University, New Haven
A Study of ASP3082 in Adults With Advanced Solid Tumors
招募中1 期
- Smilow Cancer Center at Yale New Haven Hospital, New Haven
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
招募中3 期
- Research Site, New Haven
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
招募中3 期
- Yale-New Haven Hospital, New Haven
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
招募中3 期
- Yale University School of Medicine, New Haven
Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)
招募中2 期
- Yale University, New Haven
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
招募中1/2 期
- Avenzo Therapeutics Recruiting Site, New Haven
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
招募中3 期
- Smilow Cancer Hospital at Yale New Haven, New Haven
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
招募中1 期
- Yale Cancer Center, New Haven
FOG-001 in Locally Advanced or Metastatic Solid Tumors
招募中1/2 期
- Yale University School of Medicine, New Haven
A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
招募中1/2 期
- Crinetics Study Site, New Haven
Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness
招募中1/2 期
- Yale University, New Haven
A Study of ASP1002 in Adults for Treatment of Solid Tumors
招募中1 期
- Yale University Cancer Center, New Haven
A Study of XB628 Alone and in Combination With Zanzalintinib in Participants With Recurrent Advanced or Metastatic Solid Tumors
招募中1 期
- Exelixis Clinical Site #4, New Haven
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
招募中1 期
- Smilow Cancer Hospital (Yale University), New Haven
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
招募中1 期
- Yale University, New Haven
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
招募中1/2 期
- Yale School of Medicine, North Haven · 距離 7 英里
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
招募中3 期
- Yale School of Medicine - Smilow Cancer Hospital, New Haven
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
招募中3 期
- Yale Cancer Center, New Haven
Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.
招募中1 期
- Yale Cancer Center, New Haven
其他城市的 轉移性癌症 試驗
- Houston, TX104 項研究
- New York City, NY93 項研究
- Nashville, TN70 項研究
- Boston, MA63 項研究
- Los Angeles, CA57 項研究
- St. Louis, MO54 項研究
- Arlington, VA53 項研究
- Philadelphia, PA46 項研究
- Chicago, IL45 項研究
- San Antonio, TX44 項研究
- Washington, DC43 項研究
- Dallas, TX42 項研究
New Haven 的其他研究
- 非小細胞肺癌41 項研究
- 乳癌38 項研究
- 癌症（所有類型）33 項研究
- 肺癌22 項研究
- 頭頸部鱗狀細胞癌22 項研究
- 卵巢癌21 項研究
- 大腸直腸癌20 項研究
- 前列腺癌20 項研究
- 急性髓系白血病17 項研究
- 酒精使用障礙 (AUD)17 項研究
- 鴉片類藥物過量17 項研究
- 胰臟癌16 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。